159 related articles for article (PubMed ID: 8842503)
1. Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors.
Ranieri G; Filitti V; Andriani A; Bonfantino MV; Lamontanara G; Cavallo A; Milani M; De Cesaris R
Cardiovasc Drugs Ther; 1996 May; 10(2):119-23. PubMed ID: 8842503
[TBL] [Abstract][Full Text] [Related]
2. Does calcium channel blockade and beta-adrenergic blockade affect platelet function and fibrinolysis to a varying degree?
Gleerup G; Mehlsen J; Winther K
J Cardiovasc Pharmacol; 1995 Jan; 25(1):87-9. PubMed ID: 7723358
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effect of once daily sustained release isradipine: a placebo controlled cross-over study.
Arzilli F; Gandolfi E; Del Prato C; Innocenti P; Ponzanelli F; Caiazza A; Ghisoni F; Saba P; Giuntoli F; Borgnino C
Eur J Clin Pharmacol; 1993; 44(1):23-5. PubMed ID: 8436150
[TBL] [Abstract][Full Text] [Related]
4. Decreased fibrinolytic activity and increased platelet function in hypertension. Possible influence of calcium antagonism.
Gleerup G; Winther K
Am J Hypertens; 1991 Feb; 4(2 Pt 2):168S-171S. PubMed ID: 1827012
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the antihypertensive efficacy of isradipine SRO as assessed by ambulatory blood pressure determination].
Waeber B; Soret P; Poget PN; Brunner HR
Schweiz Rundsch Med Prax; 1992 Dec; 81(50):1514-7. PubMed ID: 1465521
[TBL] [Abstract][Full Text] [Related]
6. Does antihypertensive therapy affect the natural protection against thrombosis?
Gleerup G; Hedner T; Hjørting Hansen E; Winther K
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S34-6. PubMed ID: 1720483
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the antihypertensive efficacy of once-daily sustained-release isradipine and lacidipine using 24-hour ambulatory blood-pressure monitoring.
Galderisi M; Petrocelli A; Garofalo M; Celentano A; Alfieri A; de Divitiis O
J Int Med Res; 1995; 23(4):234-43. PubMed ID: 7589766
[TBL] [Abstract][Full Text] [Related]
8. [Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].
Lohmann FW; Welzel D; Burger KJ
Arzneimittelforschung; 1993 May; 43(5):522-5. PubMed ID: 8328996
[TBL] [Abstract][Full Text] [Related]
9. Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.
Fogari R; Preti P; Lazzari P; Corradi L; Zoppi A; Fogari E; Mugellini A
Eur J Clin Pharmacol; 2003 Aug; 59(4):271-5. PubMed ID: 12830340
[TBL] [Abstract][Full Text] [Related]
10. Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects.
Smith A; McPherson J; Taylor M; Mason A; Carney S; Gillies A
J Hum Hypertens; 1997 Dec; 11(12):783-8. PubMed ID: 9468004
[TBL] [Abstract][Full Text] [Related]
11. Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus.
Mugellini A; Preti P; Zoppi A; Corradi L; Fogari E; Derosa G; Fogari R
J Hum Hypertens; 2004 Oct; 18(10):687-91. PubMed ID: 15071488
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic activity and platelet release reaction in essential hypertension.
Keskin A; Tombuloglu M; Büyükkeçeci F
Jpn Heart J; 1994 Nov; 35(6):757-63. PubMed ID: 7897822
[TBL] [Abstract][Full Text] [Related]
13. Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers.
Winther K; Gleerup G; Hedner T
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S41-4. PubMed ID: 1725542
[TBL] [Abstract][Full Text] [Related]
14. [Circadian antihypertensive effect of sustained-release isradipine in patients with essential hypertension in comparison to placebo].
Burger KJ; Anlauf M
Arzneimittelforschung; 1993 Sep; 43(9):958-62. PubMed ID: 8240458
[TBL] [Abstract][Full Text] [Related]
15. Treatment of non-insulin-dependent diabetic hypertensive patients with Ca2+ channel blockers is associated with increased platelet sensitivity to insulin.
Touyz RM; Schiffrin EL
Am J Hypertens; 1995 Dec; 8(12 Pt 1):1214-21. PubMed ID: 8998256
[TBL] [Abstract][Full Text] [Related]
16. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
Magliano MF; Amodeo C; Mion Júnior D; Francischetti E; Lima Júnior E; Nobre F; Chaves H; Ribeiro JM; Spritzer N; Jardim PC
Arq Bras Cardiol; 1993 Nov; 61(5):311-8. PubMed ID: 8147731
[TBL] [Abstract][Full Text] [Related]
17. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
18. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
[TBL] [Abstract][Full Text] [Related]
19. Effect of spirapril and hydrochlorothiazide on platelet function and euglobulin clot lysis time in patients with mild hypertension.
Gleerup G; Petersen JR; Mehlsen J; Winther K
Angiology; 1996 Oct; 47(10):951-5. PubMed ID: 8873580
[TBL] [Abstract][Full Text] [Related]
20. Isradipine improves platelet function in hypertensives.
Sinzinger H; Virgolini I; Rauscha F; Fitscha P; O'Grady J
Eur J Clin Pharmacol; 1992; 42(1):43-6. PubMed ID: 1531796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
